News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT by Gohar Manzar et al.
Gohar Manzar/faculty.mdanderson.org
Jan 3, 2025, 21:19

Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT by Gohar Manzar et al.

A recent paper by Gohar Manzar, Resident Physician at Muzaffar Qazilbash, Stem Cell Transplant Physician and Clinical Researcher at MD Anderson Cancer Center, on X:

“Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT. N=45, median OS from disease: 3.7 months. In 21 evaluable patients for response, CR 66.7%, median OS 7.3 months.”

“Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy”

Authors: Gohar Manzar, Stephanie Dudzinski, Alison Yoder, Susan Wu, Penny Fang et al.

Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT by Gohar Manzar et al.

More posts featuring Muzaffar Qazilbash.

Alison Yoder cancer CNS Multiple Myeloma Gohar Manzar MM multiple myeloma OncoDaily Oncology Penny Fang Stephanie Dudzinski Susan Wu
Special Coverage
Blog
Jan 3, 2025, 21:19
Get Ready for BGICC 2025: A Global Event in Cancer Care
Insight
Jan 3, 2025, 21:19
Advancements in urothelial carcinoma treatment - International Urology Cancer Summit
Blog
Jan 3, 2025, 21:19
Isabel Preeshagul: Calling all patients with Lung Cancer
Science
Jan 3, 2025, 21:19
Identifying a high-risk type of T-ALL by Mark Gower et al. - Princess Margaret Cancer Centre Research
Science
Jan 3, 2025, 21:19
Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT by Gohar Manzar et al.
Blog
Jan 3, 2025, 21:19
Peter Pisters: 2024 was an extraordinary year thanks to the dedication of MD Anderson Cancer Center
Career
Jan 3, 2025, 21:19
Scot Niglio: Excited to be joining the faculty at Memorial Sloan Kettering Cancer Center
Science
Jan 3, 2025, 21:19
Luis Raez: We have a lot of survivors on osimertinib alone that will need second-line therapy in the future
Insight
Jan 3, 2025, 21:08
Jasmine Kamboj: Fantastic article on Telehealth flexibilities for rural health care
Insight
Jan 3, 2025, 19:42
ESTRO/EANO Guidelines on Reirradiation of glioblastoma
Blog
Jan 3, 2025, 19:40
Wafik El-Deiry: 6 years since I started my tenure at Brown University
Blog
Jan 3, 2025, 19:38
Yakup Ergün: 2024 FDA approvals